Ad is loading...
MDOEX
Price
$10.31
Change
-$0.07 (-0.67%)
Updated
Nov 15 closing price
RNWEX
Price
$79.58
Change
-$0.79 (-0.98%)
Updated
Nov 15 closing price
Ad is loading...

MDOEX vs RNWEX

Header iconMDOEX vs RNWEX Comparison
Open Charts MDOEX vs RNWEXBanner chart's image
Morgan Stanley Developing Opportunity I
Price$10.31
Change-$0.07 (-0.67%)
VolumeN/A
CapitalizationN/A
American Funds New World R4
Price$79.58
Change-$0.79 (-0.98%)
VolumeN/A
CapitalizationN/A
MDOEX vs RNWEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MDOEX vs. RNWEX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDOEX is a StrongBuy and RNWEX is a Buy.

FUNDAMENTALS
Fundamentals
RNWEX has more cash in the bank: 60.9B vs. MDOEX (34M). RNWEX pays higher dividends than MDOEX: RNWEX (1.24) vs MDOEX (0.00). MDOEX was incepted earlier than RNWEX: MDOEX (5 years) vs RNWEX (22 years). RNWEX is a more actively managed with annual turnover of: 32.00 vs. MDOEX (15.00). RNWEX has a lower initial minimum investment than MDOEX: RNWEX (250) vs MDOEX (1000000). MDOEX annual gain was more profitable for investors over the last year : 23.77 vs. RNWEX (11.20).
MDOEXRNWEXMDOEX / RNWEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years22 years-
Gain YTD19.1916.819281%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets34M60.9B0%
Annual Yield % from dividends0.001.24-
Returns for 1 year23.7711.20212%
Returns for 3 years-21.36-15.12141%
Returns for 5 yearsN/A16.22-
Returns for 10 yearsN/A39.20-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVC2.57-0.01
-0.39%
Entravision Communication
DPZ430.43-5.54
-1.27%
Domino's Pizza
KPRX3.29-0.11
-3.15%
Kiora Pharmaceuticals Inc.
FORM37.80-1.89
-4.76%
FormFactor
PRTA14.01-2.09
-12.98%
Prothena Corp